|
Tuberculosis in HSCT patients |
|||||||
| Number |
Primary hematological disorder |
Number of CCC prior to HSCT |
HSCT conditioning regimen used |
GVHD Type/Organs involved |
Treatment of GVHD |
Organs involved by TI |
Time interval between HSCT and TI |
|
|
|||||||
| 1 |
AML, M2 |
3 |
TBI + CPM |
Acute/Liver |
Steroids |
Lungs, liver and bone marrow |
1 month |
| 2 |
AML, M3 |
4 |
TBI + CPM |
Acute/Skin |
Steroids |
Lungs |
5 months |
| 3 |
AML, M4 |
4 |
TBI + CPM |
Acute/Skin |
Steroids |
Lungs |
12 months |
|
GVHD: Graft versus host disease TBI: Total body irradiation TI: Tuberculous infection HSCT: Hematopoietic stem cell transplant CPM: Cyclophosphamide CCC: Courses of cytotoxic chemotherapy AML: Acute myeloid leukemia M2, M3, M4: Subtypes of AML | |||||||
Al-Anazi et al. Annals of Clinical Microbiology and Antimicrobials 2007 6:16 doi:10.1186/1476-0711-6-16 |
|||||||